January 16, 2026 · Form 4 insider transaction
CALLICUTT JACK W bought 100,000 shares of Galectin Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Issued pursuant to the Galectin Therapeutics, Inc. 2019 Omnibus Equity Incentive Plan.; The Restricted Stock Units, if vested, convert into Common Stock on a one for one basis.; Restricted Stock Units vest 100% on the earlier of December 31, 2026 or signing of a partnership agreement.